- Home
- / Revive Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Revive Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$2.6 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating expense total | 1.8M | 1.3M | 2.4M | 16.2M | 16.5M | 4.2M | 3.3M | 1.6M |
| Depreciation and amortization | 3.0K | 30.0K | 28.0K | 1.0K | 1.0K | 777.0K | 2.3M | 9.4M |
| EBITDA | (1.8M) | (1.3M) | (2.4M) | (16.2M) | (16.5M) | (4.2M) | (3.3M) | (1.6M) |
| EBIT | (1.8M) | (1.3M) | (4.2M) | (18.0M) | (16.6M) | (5.1M) | (5.8M) | (11.0M) |
| Interest income | 6.0K | 103.0K | 123.0K | 113.0K | 62.0K | 1.0K | ||
| Interest expense | 2.0K | 6.0K | 6.0K | 7.0K | 4.0K | 3.0K | 3.0K | |
| Pre tax profit | (1.8M) | (1.3M) | (5.4M) | (20.1M) | (17.8M) | (6.3M) | (5.6M) | (11.0M) |
| Net Income | (1.8M) | (1.3M) | (5.4M) | (20.1M) | (17.8M) | (6.3M) | (5.6M) | (11.0M) |